ICPO Foundation-International Centers for Precision Oncology

Are you ready to contribute to AI transformative role in theranostics? Then don´t miss this opportunity and apply for the   ICPO AI Research Grant 2025 🔬 Topic: „Curation & Standardization of Theranostics Datasets“   ✅ Objective: Curate, standardize, and annotate theranostics datasets (imaging and non-imaging) ✅ Relevance: Supports high-quality reference data for AI training in theranostics ✅ Outcome: Comprehensive, annotated database available to ICPO partners   🗓 Application deadline:  November 1, 2025 More info: https://lnkd.in/dW7sg8xn ICPO Foundation-International Centers for Precision Oncology Team: Odile JAUMERichard P. Baum, Martin Reuter, Dr. Marwa A. Hakkam, Karim Bouterfa, Susanne Simon, Andreas Nötzold, Katja Schorn #ICPOFoundation #Research #AI #ArtificialIntelligence #Data #Science #Funding #Grant #Radiotheranostics #Theranostics #RadiomolecularPrecisionOncology, #Radiopharmaceuticals #ICPOClinicalTheranosticsCentersOfExcellence #ICPOCenter, #CancerCare #ICPOAcademyForTheranostics #Research #AI #ArtificialIntelligence 

The ICPO Foundation Newsletter July 2025 Edition is out! 🌟 As of today, our network of ICPO Clinical Theranostics Centers of Excellence has expanded to 22 worldwide. By the end of the year, this number will have more than doubled. 🌟 We are happy to announce the establishment of the RLT Angels Association in June 2025, a new initiative co-founded by Novartis, GE HealthCare, RayzeBio, a Bristol Myers Squibb company, EANM and the ICPO Foundation. 🌟 Now dive into the latest news about our ICPO Centers, new offerings from the ICPO Academy for Theranostics, and our research projects, including an AI Research Call. You don´t want to miss our news? Register here for our ICPO Newsletter: https://lnkd.in/d9JjSg-f   ICPO Community mentioned in this newsletter: Patricia Bautista-Penalosa, MD, FPSNM, FANMB, Cecilia Carreras Velázquez, Partha Choudhury, Akram Al-Ibraheem, Nuriye Ozlem Kucuk, Rodney Hicks, AM, Shelley Simon, Masha Maharaj, Yehia Omar, Matthias Eiber, Vasko Kramer, Mohamed Halim Zaki, Nadine Holzleitner, Elcin Zan, MD, Oliver Buck, RLT Angels, European Association of Nuclear Medicine (EANM), Desiree Deandreis, Fuad Novruzov, MD, PhD, Dr. Batool Albalooshi, Society of Nuclear Medicine and Molecular Imaging (SNMMI), UroTeragLATAM, ALASBIMN ICPO Foundation-International Centers for Precision Oncology Team: Odile JAUME, Richard P. Baum, Martin Reuter, Dr. Marwa A. Hakkam, Karim Bouterfa, Susanne Simon, Andreas Nötzold, Katja Schorn #ICPOFoundation #Radiotheranostics #Theranostics #RadiomolecularPrecisionOncology, #Radiopharmaceuticals #ICPOClinicalTheranosticsCentersOfExcellence #ICPOCenter, #CancerCare #ICPOAcademyForTheranostics

ICPO Foundation-International Centers for Precision Oncology awarded Dr. Nadine Holzleitner from the Technische Universität München with the Maurits W. Geerlings Next Generation Award 2025. This award honors researchers for groundbreaking research in Actinium-225 radiopharmaceutical science. Dr. Nadine Holzleitner convinced with her pioneering work: "Preclinical evaluation of 225Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha Therapy (TAT)". The collaborative project between TUM and the University of California, Los Angeles (UCLA) was designed for two types of aggressive cancer, such as medullary thyroid carcinoma and small cell lung cancer, with limited current treatment options. Dr. Elcin Zan, MD, Chair of the Division of Nuclear Medicine Cleveland Clinic, USA, and Chair of the evaluation committee, together with Oliver Buck, Trustee of the ICPO Foundation, presented the award during the “ICPO Forum for Theranostics in Precision Oncology 2025” in Munich. Odile JAUME, CEO of the ICPO Foundation, stated: "Dr. Nadine Holzleitner's work is an outstanding example of translational science. Her contributions not only advanced the field of nuclear medicine but also brought us one step closer to more effective and targeted cancer therapies in radiotheranostics for patients worldwide." Read the full press release here: https://lnkd.in/dG2-Vjyq #ICPOFoundation #MauritsWGeerlingsAward2025 #TUM #Science #Award #TargetingAlphaTherapy #TAT #Theranostics #Radiotheranostics #PrecisionOncology #RadiomolecularPrecisionOncology #ICPO #NuclearMedicine #MolecularImaging #TheranosticsCenter   ICPO Foundation-International Centers for Precision Oncology team: Odile JAUME, Richard P. Baum, Martin Reuter, Dr. Marwa A. Hakkam, Karim Bouterfa, Susanne Simon, Andreas Nötzold, Katja Schorn

🌍ICPO Foundation-International Centers for Precision Oncology expands its theranostics center network in India, Jordan, and South Africa ✨By enhancing clinical standards these partnerships empower ICPO Centers to achieve better patient outcomes and expanding access to radiotheranostics. The following theranostics centers represented by their directors have joined the ICPO Clinical Theranostics Center of Excellence network: 🤝 @Aster Whitefield Hospital in Bangalore, India; Dr. Prathap. H. J., Head of Nuclear Medicine & Theranostics Department 🤝The Rajiv Gandhi Cancer Institute & Research Centre (RGCIRC) in New Delhi, India Dr. Partha Choudhury, Director of Nuclear Medicine 🤝King Hussein Cancer Center (KHCC) in Amman, Jordan Dr. Akram Al-Ibraheem, Chairman & Professor at Nuclear Medicine Department Umhlanga Molecular Imaging & Therapy Centre in Umhlanga, South Africa Dr. Masha Maharaj, Head of Nuclear Medicine Department Odile JAUME, CEO of the ICPO Foundation, commented: "We are delighted to welcome four new ICPO Clinical Centers of Excellence from three different regions into our ICPO network. This expansion strengthens global collaboration in radiotheranostics and reflects growing trust in ICPO's standards, best practices, and services. By uniting expertise across our community, we move closer to treating more cancer patients with radiotheranostics and improving patient outcomes worldwide." ✍You want to join the ICPO Clinical Theranostics Centers of Excellence Network? The ICPO Foundation offers a structured accreditation pathway that recognizes centers' current achievements and provides a clear roadmap toward future development. Apply here: https://lnkd.in/dkKCdsrv Network of ICPO Clinical Theranostics Center (selection): Melbourne Theranostic Innovation Centre; Fortis Memorial Research Institute - India, Apollo Hospitals, Chennai, Misr Radiology Center, American Hospital Dubai, St. Luke's Hospital, NuMeRI, Azerbaijan Nuclear Medicine Centre, Read the full press release here: https://lnkd.in/dt2uKGHu   #ICPOFoundation #ICPOCenterNetwork #TheranosticsCenter #Theranostics #Radiotheranostics #PrecisionOncology #ProstateCancer #NeuroendocrineTumors #ICPO #NuclearMedicine #MolecularImaging   ICPO Foundation-International Centers for Precision Oncology Team: Odile JAUME, Richard P. Baum, Martin Reuter, Dr. Marwa A. Hakkam, Karim Bouterfa, Susanne Simon, Andreas Nötzold, Katja Schorn      

🌟 The ICPO team is ready for the SNMMI 2025 in vibrant New Orleans! 🌟 Visit us on booth NP 6 and discover: ✅The growing ICPO Clinical Theranostics Center of Excellence (CoE) network ✅The ICPO services to elevate ICPO Clinical Centers into Comprehensive CoEs ✅Sponsoring opportunities to empower the next generation of "Theranosticians" through stipends for the ICPO Academy for Theranostics Talk to our team in New Orleans: Odile JAUME, CEO; Richard P. Baum, Trustee of the ICPO Foundation and President of the ICPO Academy for Theranostics; Martin Reuter, CFO; Karim Bouterfa, Academy and Centers Project Manager 🌍 Let´s shape the future of cancer care together! 🌍 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2025 📍 New Orleans, USA 📅 June 21–24, 2025 Website: https://lnkd.in/d69RsbFC   #ICPOFoundation #SNMMI #Radiotheranostics #Theranostics #Cancer #PatientOutcomes #ICPOAcademyForTheranostics #NewOrleans ICPO Foundation-International Centers for Precision Oncology Team: Odile JAUME, Richard P. Baum, Martin Reuter, Dr. Marwa A. Hakkam, Karim Bouterfa, Susanne Simon, Andreas Nötzold, Katja Schorn

ICPO Foundation-International Centers for Precision Oncology Foundation is proud to take part in the RLT Angels Association as a founding member!   This new initiative is dedicated to maximizing patient access to radiomolecular precision oncology, systematically expanding health system ability to deliver radioligand imaging (RLI) and radioligand therapies (RLT) and improving the experience and outcomes for patients globally. “As a founding member of RLT Angels, the ICPO Foundation believes in the power of partnership and mission alignment to drive meaningful change in healthcare. By leveraging our collective expertise – including ICPO’s education and accreditation resources, as well as our global community outreach – we can enhance accessibility and ensure that innovative therapies reach those who need them most,” said Prof. Richard P. Baum, Board member of the RLT Angels Association, Trustee of the ICPO Foundation, and President of the ICPO Academy for Theranostics. Let’s shape the future of cancer care together! #ICPOFoundation #RLT #RLI #RLTAngels #ProstateCancer #NeuroendocrineTumors #Theranostics #Radiotheranostics #PrecisionOncology #ICPO #NuclearMedicine #MolecularImaging #TheranosticsCenter #PatientOutcomes   ICPO Foundation Team: Odile JAUME, Richard P. Baum, Martin Reuter, Dr. Marwa A. Hakkam, Karim Bouterfa, Susanne Simon, Andreas Nötzold, Katja Schorn

The Lancet Regional Health - Europe published today an article with the topic:   “ICPO Forum 2025: advancing theranostics in precision oncology” Authors: Richard P. Baum, Odile JAUME   Integrated into the Lancet Article – Key recommendations to shape the future of theranostics from the ICPO Forum for Theranostics in Precision Oncology on May 2025 in Munich at Technische Universität München Campus: 1.       Scaling patient access 2.       Harmonizing medical treatments 3.       Addressing systemic barriers 4.       Supporting global theranostics networks 5.       Reinforcing scalable and inclusive theranostics training 6.       Enabling collaborative research & innovation 7.       Structuring AI integration Read the full article here: ICPO Forum 2025: https://lnkd.in/dhsJ8tqR   Speakers ICPO Forum: Richard P. Baum; Stephanie E. Combs; Josh Mailman; Rodney Hicks, AM; Francesco Giammarile, Vikas Prasad; Desiree Deandreis; Matthias Eiber; Cathy Cutler; Pierre-Yves Salaün; Patricia Bautista-Penalosa, MD, FPSNM, FANMB; Partha Choudhury; Masha Maharaj; Agolti Mariela; Univ.-Prof. Dr. Frederik Giesel, MD, MBA; David Cade; Akram Al-Ibraheem; Danielle Ralic; Tom Stargardt; Ana Katrina Mapanao; Lingzhi (Lance) Hu; Sergio Calvo; Lalith Kumar Shiyam Sundar, PhD; Mike Sathekge; Neil Quigley; Hugo Levillain; Vicki Jardine; Wolfgang Weber, Antonis Kalemis, Yehia Omar Moderators of the ICPO Forum: Richard P. Baum, Rodney Hicks, AM, Ken Herrmann, Thomas Beyer, PhD, MBA and Josh Mailman, Efrain Perini Presenter Maurits Geerlings Award on Ac225: Elcin Zan, MD and Oliver Buck ICPO Foundation-International Centers for Precision Oncology Team: Odile Jaume, Richard P. Baum, Martin Reuter, Dr. Marwa A. Hakkam, Karim Bouterfa, Susanne Simon, Andreas Nötzold, Katja Schorn #ICPOForum #ICPOFoundation #Theranostics #Radiotheranostics #FutureOfTheranostics #PrecisionOncology #ICPOForum #NuclearMedicine #Oncology #Conference #CuttingEdge #Cancer #Tumor #AI #TargetedAlphaTherapy #Radiopharmaceuticals #Innovation #FAP

Further initiatives in this field will unlock the full potential of Radiotheranostics! Through continued global collaborations, we are paving the way for additional applications across a growing range of cancer indications offering improved patient outcomes and better quality of life for even more patients.   #ICPOFoundation #RLT #RLI #RLTAngels #ProstateCancer #NeuroendocrineTumors #Theranostics #Radiotheranostics #PrecisionOncology #ICPO #NuclearMedicine #MolecularImaging #TheranosticsCenter #PatientOutcomes   ICPO Foundation-International Centers for Precision Oncology Team: Odile JAUME, Richard P. Baum, Martin Reuter, Dr. Marwa A. Hakkam, Karim Bouterfa, Susanne Simon, Andreas Nötzold, Katja Schorn

Optimize, Educate and Certify: Learn more about the ICPO Services to Theranostics Centers at SNMMI 2025   If you're interested in fostering the growth of theranostics centers and patient access to radiotheranostics globally or would like to learn more about the network of ICPO Centers of Excellence and the ICPO Academy for Theranostics (www.theranostics.academy), don’t miss the opportunity to check on ICPO services and to connect during the congress: 🌍 Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2025 📍 New Orleans, USA 📅 June 21–24, 2025 Meet with the ICPO Foundation at ICPO Booth NP 6: Odile JAUME, CEO of the ICPO Foundation, Richard P. Baum, President of the ICPO Academy for Theranostics, Martin Reuter, CFO of the ICPO Foundation Karim Bouterfa, ICPO Academy & Centers Project Manager. More info: www.icpo.foundation   #ICPOFoundation #SNMMI #ProstateCancer #NeuroendocrineTumors #Theranostics #Radiotheranostics #PrecisionOncology #ICPO #NuclearMedicine #MolecularImaging #TheranosticsCenter #Congress #NewOrleans #USA   ICPO Foundation-International Centers for Precision Oncology Team: Odile JAUME, Richard P. Baum, Martin Reuter, Dr. Marwa A. Hakkam, Karim Bouterfa, Susanne Simon, Andreas Nötzold, Katja Schorn  

Men’s Health Week: Advancing the fight against prostate cancer and neuroendocrine tumors   Men’s Health Week is a timely reminder to raise awareness about the power of innovative cancer care – especially when it comes to prostate cancer, one of the most common cancers affecting men worldwide. Neuroendocrine tumors, though rarer, also create serious health challenges.   Thanks to groundbreaking advances in radiotheranostics targeted treatment is available for cancer patients combining diagnostics and therapy in a single, personalized approach. Using radiolabeled molecules, clinicians can precisely locate and treat cancer cells while sparing healthy tissue – significantly improving both survival and quality of life for many patients.   Let’s use this week to encourage awareness and spotlight the life-changing potential of radiotheranostics.   Listen to our ICPO patient interviews here: https://lnkd.in/e7xSqXsZ   ICPO Foundation-International Centers for Precision Oncology Team: Odile JAUME, Richard P. Baum, Martin Reuter, Dr. Marwa A. Hakkam, Karim Bouterfa, Susanne Simon, Andreas Nötzold, Katja Schorn   #ICPOFoundation #MensHealthWeek #ProstateCancerAwareness #ProstateCancer #NeuroendocrineTumors #Theranostics #Radiotheranostics #PrecisionOncology #ICPO #NuclearMedicine